EQRR:NSD-ProShares Equities for Rising Rates ETF

ETF | Drug Manufacturers |

Last Closing

USD 39.29

Change

+0.30 (+0.77)%

Market Cap

USD 3.29M

Volume

100.00

Analyst Target

N/A
Analyst Rating

N/A

ducovest Verdict

Verdict

About

Unadjusted Closing Price

Adjusted Closing Price

Share Volume

Relative Performance (Total Returns)

Compare
Relative Returns (From:    To: 2019-10-16 )

Largest Industry Peers for Drug Manufacturers

ETFs Containing EQRR

N/A

Market Performance

  Market Performance vs. Industry/Classification (Drug Manufacturers) Market Performance vs. Exchange
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
YTD  
Capital Gain 5.56% 71% C- 48% F
Dividend Return 1.08% 100% F 24% F
Total Return 6.64% 86% B+ 47% F
Trailing 12 Months  
Capital Gain -15.67% 57% F 39% F
Dividend Return 1.47% 60% D- 31% F
Total Return -14.19% 57% F 39% F
Trailing 5 Years  
Capital Gain N/A N/A N/A N/A F
Dividend Return N/A N/A N/A N/A F
Total Return N/A N/A N/A N/A F
Average Annual (5 Year Horizon)  
Capital Gain -3.90% 86% B+ 29% F
Dividend Return -2.86% 86% B+ 29% F
Total Return 1.03% 100% F 27% F
Risk Return Profile  
Volatility (Standard Deviation) 12.67% 100% F 82% B
Risk Adjusted Return -22.61% 43% F 25% F
Market Capitalization 3.29M 14% F 3% F

Annual Financials (USD)

Quarterly Financials (USD)

Analyst Rating

Target Price Action Rating Action Analyst Rating Price Date

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

What to like:
Underpriced compared to earnings

The stock is trading low compared to its peers on a price to earning basis and is in the top quartile. It may be underpriced but do check its financial performance to make sure there is no specific reason.

Superior total returns

The stock has outperformed its sector peers on average annual total returns basis in the past 5 years (for a hold period of at least 12 months) and is in the top quartile.

Low volatility

The stock’s annual returns have been stable and consistent compared to its sector peers(for a hold period of at least 12 months) and is in the top quartile. Although stability is good, also keep in mind it can limit returns.

What to not like:
Poor risk adjusted returns

This company is delivering below median risk adjusted returns in its peers. Even if it is outperforming on returns , the returns are unpredictable. Proceed with caution.

Low market capitalization

This is among the smaller entities in its sectors with below median market capitalization. That may make it less stable in the long run unless it has a unique technology or market which can help it grow or get acquired in future.